PREMIER Biosoft International today announced the world wide release of SimGlycan® version 2.90
SimGlycan, a comprehensive MS/MS data analysis tool, is now a high throughput application, being able to analyze 500 profiles in a single search run. Also improved is the ability to identify complex glycosaminoglycans.
Palo Alto, California -- April 7, 2010, PREMIER Biosoft International today announced the worldwide release of version 2.90 of its glycan and glycopeptide elucidation tool, SimGlycan. The program can now analyze upto 500 profiles at a time. Furthermore, users can create a search parameters template to apply to all the peaklist datasets and generate a comprehensive report of their findings.
"As glycans and glycopeptides are increasingly being used for therapeutics, there is a need for improved methods for their analysis, especially for biopharmaceuticals," said Kay Brown, V.P. Business Development and Marketing.
With version 2.90, SimGlycan® has taken a step forward in identifying complex glycosaminoglycan structures even when modified with substituents such as sulfate, phosphate and ethanolamine. The program generates an annotated spectra which displays subsequent loss of substituents from its corresponding glycosidic fragments.
For details, please visit: http://www.premierbiosoft.com/glycan/index.html
About PREMIER Biosoft International:
Founded in 1994, is a group of computer scientists and biologists dedicated to producing cutting edge intuitive software for research in life sciences. Our goal is to study the most recent innovations in life sciences and translate them into software products to aid research.
More information is available at http://www.premierbiosoft.com
PREMIER Biosoft International